Creative Planning
MIRA icon

Creative Planning’s MIRA Pharmaceuticals MIRA Stock Holding History

Creative Planning’s Portfolio MIRA Stock Details MIRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-22,599
Closed -$34.1K – 4161
2025
Q4 		$34.1K Hold
22,599
– – ﹤0.01% 3827
2025
Q3 		$30.7K Hold
22,599
– – ﹤0.01% 3790
2025
Q2 		$27.3K Buy
+22,599
New +$26.1K ﹤0.01% 3576

Other funds holding MIRA

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CSI
Cross Staff Investments Pittsford, New York $178M AUM 21.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SEM
Suncoast Equity Management Tampa, Florida $833M AUM 11.9% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
FAB
First American Bank Dundee, Illinois $1.79B AUM 30.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Creative Planning's MIRA Position: Q1 2026 in Review

Creative Planning sold out of MIRA Pharmaceuticals (MIRA) in Q1 2026, closing a stake of 22,599 shares — an estimated $34.1K sold.

Creative Planning first reported a position in MIRA in Q2 2025 and held it in 3 quarters. The position peaked at $34.1K in Q4 2025. 26 funds tracked by Wall St. Rank hold MIRA as of Q1 2026.

  • Creative Planning reported no remaining MIRA Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Creative Planning sold 22,599 MIRA Pharmaceuticals shares in Q1 2026, an estimated $34.1K.
  • Creative Planning first reported a position in MIRA Pharmaceuticals in Q2 2025 and held it in 3 quarters.
  • Creative Planning's MIRA Pharmaceuticals position peaked at $34.1K in Q4 2025.
  • 26 funds tracked by Wall St. Rank held MIRA Pharmaceuticals as of Q1 2026.

Based on Creative Planning's 13F filing for Q1 2026, filed 12 May 2026.